Beijing Leadman Biochemistry Co.,Ltd.

Equities

300289

CNE100001C22

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
4.31 ^CNY	-3.36%		+4.87%	-29.92%

Apr. 25	Beijing Leadman Biochemistry Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 28	Beijing Leadman Biochemistry Co.,Ltd. Proposes Final Cash Dividend for 2023	CI

Shenzhen Uni-medica Technology Co., Ltd. announced that it has received CNY 20 million in funding from Beijing Leadman Biochemistry Co.,Ltd.

December 18, 2022

On December 19, 2022, Shenzhen Uni-medica Technology Co., Ltd. recently closed the transaction. The company completed the industrial and commercial change registration and company articles of association filing procedures for this capital increase.

Latest news about Beijing Leadman Biochemistry Co.,Ltd.

Beijing Leadman Biochemistry Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Beijing Leadman Biochemistry Co.,Ltd. Proposes Final Cash Dividend for 2023	Mar. 27	CI
Beijing Leadman Biochemistry Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 27	CI
Leadman Biochemistry Unit Obtains Shanghai Clearance for Fatty Acid Kit	Mar. 15	MT
Beijing Leadman Biochemistry Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-23	CI
Beijing Leadman Biochemistry Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-11	CI
Beijing Leadman Biochemistry Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-20	CI
Beijing Leadman Biochemistry Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-24	CI
Shenzhen Uni-medica Technology Co., Ltd. announced that it has received CNY 20 million in funding from Beijing Leadman Biochemistry Co.,Ltd.	22-12-18	CI
Shenzhen Uni-medica Technology Co., Ltd. announced that it expects to receive CNY 20 million in funding from Beijing Leadman Biochemistry Co.,Ltd.	22-11-07	CI
Beijing Leadman Biochemistry Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-21	CI
Beijing Leadman Biochemistry Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-18	CI
Beijing Leadman Biochemistry Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-22	CI
Beijing Leadman Biochemistry Co.,Ltd. Approves Cash Dividend for the Year 2021	22-04-13	CI
Beijing Leadman Biochemistry Co.,Ltd. Proposes Final Dividend for the Year 2021	22-03-21	CI
Beijing Leadman Biochemistry Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-18	CI
Beijing Leadman Biochemistry Co.,Ltd. Approves Board Appointments	21-12-01	CI
Beijing Leadman Biochemistry Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-27	CI
Beijing Yongtai Enter into the Lease Agreement with Beijing Leadman Biochemistry Co.,Ltd	21-10-11	CI
Beijing Leadman Biochemistry : Raises $85 Million From Private Share Sale; Shares Rise Nearly 3%	21-09-03	MT
Beijing Leadman Biochemistry Co.,Ltd. announced that it has received CNY 556.6 million in funding from Guangzhou GET Technologies Development Co., Ltd	21-08-17	CI
Beijing Leadman Biochemistry Co.,Ltd. Announces Earnings Results for the Half Year Ended June 30, 2021	21-08-12	CI
Beijing Leadman Biochemistry Co.,Ltd. Reports Earnings Results for the First quarter Ended March 31, 2021	21-04-27	CI
Beijing Leadman Biochemistry Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-16	CI
Beijing Leadman Biochemistry Co.,Ltd. Announces Dismissal of Luo Haobo as a Director	20-12-17	CI

Chart Beijing Leadman Biochemistry Co.,Ltd.

Duration

Period

Chart Beijing Leadman Biochemistry Co.,Ltd.

More charts

Company Profile

Beijing Leadman Biochemistry Co., Ltd is a China-based company principally engaged in the research, development, production and sales of in-vitro diagnostic reagents. Its diagnostic reagents include chemiluminescence diagnostic reagents and biochemical diagnostic agents, such as hepatitis B virus attributes and tumor markers. The Company also produces diagnostic instruments and biochemical raw materials. Its diagnostic instruments include automatic luminescence immunity analyzers, among others. Its products are applied in various fields, including liver diseases, kidney diseases, cardiovascular diseases, immunological diseases and diabetes, among others. The Company mainly operates businesses in domestic market.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-04-29 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
BEIJING LEADMAN BIOCHEMISTRY CO.,LTD.	-29.92%	324M
BIOMÉRIEUX	+0.89%	12.8B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-10.29%	7.61B
DIASORIN S.P.A.	+1.78%	5.41B
AUTOBIO DIAGNOSTICS CO., LTD.	-1.16%	4.51B
LANTHEUS HOLDINGS, INC.	+5.74%	4.49B
10X GENOMICS, INC.	-50.70%	3.29B
ANDON HEALTH CO., LTD.	+12.21%	2.73B
VITROLIFE AB	-16.13%	2.02B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-11.50%	1.73B

Diagnostic & Testing Substances